South African Brain Research Institute
- Research works
- 101 ▲ 38% vs 2013–17
- Citations
- 1.5k 15.3 per fractional work
- Top-10% rate
- 17.4% record average 16.5%
- Open access
- 34% world 28%
Not ranked overall: South African Brain Research Institute is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Neuroscience, 9.8×. Every wedge is a field page.
- Neuroscience 9.8×
- Business, Management and Accounting 3.4×
- Health Professions 2.7×
- Medicine 2.3×
- Nursing 2.0×
- Economics, Econometrics and Finance 1.2×
- Immunology and Microbiology 0.8×
- Environmental Science 0.6×
- Arts and Humanities 0.4×
- Psychology 0.4×
- Agricultural and Biological Sciences 0.4×
- Social Sciences 0.4×
- Biochemistry, Genetics and Molecular Biology 0.3×
- Computer Science 0.3×
- Mathematics 0.3×
Who are the top researchers at South African Brain Research Institute?
Ranked on the composite score, Mark A. Gillman lead among researchers whose main affiliation is South African Brain Research Institute.
- 1 Mark A. Gillman South Africa · #439,090 worldwide 81 citations · 25 works
Which keywords describe research at South African Brain Research Institute?
By fractional works in all years, weighted toward what it does more of than the world: Depression, Stress, Cancer Therapy, Neuroprotection, Oxidative Stress, Neuroinflammation, Neurological Disorders and Neuroimaging.
- Placebo
- Ketamine
- Alzheimer's Disease
- Epoxyeicosatrienoic Acids
- Treatment-Resistant Depression
- Hypertension
- Thiamine Deficiency
- Neuropathology
- Metabolic Syndrome
- Nociception
- Sigma-1 Receptor
- Neuropeptides
- Neuropathic Pain
- Synaptic Plasticity
- Calcitonin Gene-Related Peptide
- Neuroimaging
- Neurological Disorders
- Neuroprotection
- Stress
- Oxidative Stress
- Depression
- Inflammation
- Cancer Therapy
- Neuroinflammation
- Epidemiology
- Neurodegenerative Diseases
- Neurobiological Mechanisms
- Anxiety
- Chaperone
- Receptors
- Central Sensitization
- Cognitive Impairment
- Metabolism
- Anesthesia
- Wernicke-Korsakoff Syndrome
- Management
- Arachidonic Acid
- Sedation
- Antidepressant
- Nocebo
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Depression10▲ 13×8 topics
- Oxidative Stress9▲ 4.8×14 topics
- Inflammation8▲ 3.3×10 topics
- Stress7▲ 18×5 topics
- Cancer Therapy7▲ 11×2 topics
- Neuroprotection7▲ 19×4 topics
- Neuroinflammation7▲ 25×4 topics
- Neurological Disorders7▲ 9.9×10 topics
- Epidemiology7▲ 1.63×19 topics
- Neuroimaging6▲ 22×5 topics
- Neurodegenerative Diseases5▲ 25×2 topics
- Calcitonin Gene-Related Peptide5▲ 61×2 topics
- Neurobiological Mechanisms5▲ 111×2 topics
- Synaptic Plasticity5▲ 17×3 topics
- Anxiety5▲ 14×2 topics
- Neuropathic Pain5▲ 62×2 topics
- Chaperone5▲ 253×1 topic
- Neuropeptides5▲ 46×1 topic
- Receptors5▲ 81×1 topic
- Sigma-1 Receptor5▲ 326×1 topic
- Central Sensitization5▲ 64×1 topic
- Nociception5▲ 75×1 topic
- Cognitive Impairment5▲ 20×5 topics
- Metabolic Syndrome4▲ 5.0×6 topics
- Metabolism4▲ 6.6×5 topics
- Neuropathology4▲ 48×2 topics
- Anesthesia4▲ 36×2 topics
- Thiamine Deficiency4▲ 217×1 topic
- Wernicke-Korsakoff Syndrome4▲ 217×1 topic
- Hypertension4▲ 9.9×3 topics
- Management4▲ 4.5×6 topics
- Treatment-Resistant Depression4▲ 49×2 topics
- Arachidonic Acid3▲ 101×1 topic
- Epoxyeicosatrienoic Acids3▲ 101×1 topic
- Sedation3▲ 37×2 topics
- Alzheimer's Disease3▲ 10×3 topics
- Antidepressant3▲ 96×1 topic
- Ketamine3▲ 96×1 topic
- Nocebo3▲ 132×1 topic
- Placebo3▲ 132×1 topic
Which research topics does South African Brain Research Institute publish most on?
By volume in 2022–2025: Treatment of Major Depression, Business Strategies and Innovation, Biotechnology and Related Fields and Alzheimer's disease research and treatments.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Treatment of Major Depression Pharmacology 1 works
- 2 Business Strategies and Innovation Strategy and Management 0 works
- 3 Biotechnology and Related Fields Public Health, Environmental and Occupational Health 0 works
- 4 Alzheimer's disease research and treatments Physiology 0 works
- 5 Anesthesia and Neurotoxicity Research Developmental Neuroscience 0 works
- 6 Functional Brain Connectivity Studies Cognitive Neuroscience 0 works
- 7 Dementia and Cognitive Impairment Research Psychiatry and Mental health 0 works
- 8 Aging, Elder Care, and Social Issues General Health Professions 0 works
- 9 Anesthesia and Sedative Agents Anesthesiology and Pain Medicine 0 works
- 10 Neuroscience and Neuropharmacology Research Cellular and Molecular Neuroscience 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has South African Brain Research Institute's research output changed?
Output in 2018–2022 was 38% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Johannesburg
- University of the Witwatersrand
- University of Johannesburg
- National Health Laboratory Service
- South African Institute for Medical Research
- Chris Hani Baragwanath Hospital
- Mintek
- Eskom (South Africa)
- Johannesburg Hospital
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.